Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Psychosomatic Medicine|May 31, 2001
Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patientsL Capuron, A Ravaud, R DantzerJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapyL Capuron, A Ravaud, R DantzerPsychological Medicine|April 28, 1999
Attentional and mnemonic deficits associated with infectious disease in humansL Capuron, D Lamarque, R Dantzer, et al.Current Neuropharmacology|August 4, 2020
Tetrahydrobioterin (BH4) Pathway: From Metabolism to NeuropsychiatryH Fanet, L Capuron, N Castanon, et al.Neuroreport|April 26, 1996
Cognitive sequelae of propofol anaesthesiaJ Sanou, G Goodall, L Capuron, et al.Brain, Behavior, and Immunity|July 5, 2022
Tetrahydrobiopterin modulates the behavioral neuroinflammatory response to an LPS challenge in miceS Vancassel, H Fanet, N Castanon, et al.Molecular Psychiatry|June 26, 2002
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapyL Capuron, A Ravaud, P J Neveu, et al.Psychoneuroendocrinology|October 5, 2001
Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapyL Capuron, A Ravaud, N Gualde, et al.Diabetes & Metabolism|January 15, 2013
Quality of life after Roux-en-Y gastric bypass and changes in body mass index and obesity-related comorbiditiesC Julia, C Ciangura, L Capuron, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 20, 2000
Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapyM Maes, L Capuron, A Ravaud, et al.Pageof 2